HYRIMOZ
adalimumab-adaz · KIT · Cordavis Limited
No Recall HistoryCurrently in Shortage
Plain English
HYRIMOZ is a kit containing adalimumab-adaz. Manufactured by Cordavis Limited.
Key Facts
- Brand Name
- HYRIMOZ
- Generic Name
- adalimumab-adaz
- NDC Code (Product)
83457-112- Manufacturer
- Cordavis Limited
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA761071
- Drug Class
- Tumor Necrosis Factor Blocker [EPC]
- Marketing Start
- 12/15/2023
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective1,310 reports
off label use1,306 reports
arthralgia1,116 reports
fatigue1,089 reports
pain1,066 reports
diarrhoea926 reports
general physical health deterioration860 reports
rheumatoid arthritis816 reports
malaise785 reports
condition aggravated715 reports
Frequently Asked Questions
What is HYRIMOZ used for?
HYRIMOZ contains adalimumab-adaz. It is a kit taken as directed. Consult your doctor for specific uses.
Is HYRIMOZ a controlled substance?
HYRIMOZ is not classified as a controlled substance by the DEA.
What is the generic name for HYRIMOZ?
The generic name for HYRIMOZ is adalimumab-adaz. There are 2 other brand versions of adalimumab-adaz.
What is the NDC code for HYRIMOZ ?
The NDC (National Drug Code) for HYRIMOZ is 83457-112, listed by Cordavis Limited.